BioCentury
ARTICLE | Financial News

Adamas Pharmaceuticals completes IPO

April 14, 2014 7:00 AM UTC

Adamas Pharmaceuticals Inc. (NASDAQ:ADMS), Emeryville, Calif. Business: Neurology, Infectious Date completed: 4/9/14 Type: IPO Raised: $48 million Shares: 3 million Price: $16 Shares after offering: 1...